PCMA Statement on the Administration's Proposal Requiring List Prices of Drugs in TV Ads

WASHINGTON, Oct. 15, 2018 /PRNewswire/ -- Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on the Department of Health and Human Services' proposal requiring drug companies to disclose the list price of prescription drugs in television ads:

"We share the Administration's goal of reducing prescription drug prices. Pharmacy benefit managers (PBMs) foster competition among drugmakers, resulting in lower costs for consumers.

We believe that list prices of drugs should be included in drug manufacturers' communications with prescribers to help patients make informed treatment choices.

The most direct way to reduce costs and improve access to prescription drugs is for drugmakers to cut their prices, and we look forward to working with the Administration and Congress to accomplish this goal."

PCMA is the national association representing America's pharmacy benefit managers (PBMs). PBMs administer prescription drug plans for more than 266 million Americans who have health insurance from a variety of sponsors including: commercial health plans, self-insured employer plans, union plans, Medicare Part D plans, the Federal Employees Health Benefits Program (FEHBP), state government employee plans, Medicaid plans, and others.

SOURCE Pharmaceutical Care Management Association